Liquid biopsy is a technique that isolates and detects circulating nucleic acids (DNA or RNA), exosomes, and circulating tumor cells (CTCs) for diagnosing primary tumors or detecting the stage of metastatic lesions in tissues. Liquid biopsies are tests conducted on blood samples that examine biomarkers shed by tumors, such as cancer cells or pieces of tumor DNA. This study comprises products and services of liquid biopsies. The study estimates the revenue generated from the sales of liquid biopsy products and services. The study scope focuses applications of liquid biopsy products and services for various cancer applications. Furthermore, the report excludes revenue generated from post-sale services of liquid biopsy products and services.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICES

CHAPTER 5: LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER 

CHAPTER 6: LIQUID BIOPSY MARKET, BY CANCER TYPE

CHAPTER 7: LIQUID BIOPSY MARKET, BY END USER 

CHAPTER 8: LIQUID BIOPSY MARKET, BY REGION

CHAPTER 9: COMPANY PROFILES